Viking Therapeutics (VKTX) Assets Average (2016 - 2025)
Historic Assets Average for Viking Therapeutics (VKTX) over the last 11 years, with Q4 2025 value amounting to $727.6 million.
- Viking Therapeutics' Assets Average fell 2118.21% to $727.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $727.6 million, marking a year-over-year decrease of 2118.21%. This contributed to the annual value of $812.0 million for FY2025, which is 2719.58% up from last year.
- Latest data reveals that Viking Therapeutics reported Assets Average of $727.6 million as of Q4 2025, which was down 2118.21% from $783.6 million recorded in Q3 2025.
- Viking Therapeutics' 5-year Assets Average high stood at $957.2 million for Q2 2024, and its period low was $159.7 million during Q1 2023.
- Over the past 5 years, Viking Therapeutics' median Assets Average value was $325.7 million (recorded in 2023), while the average stood at $480.9 million.
- As far as peak fluctuations go, Viking Therapeutics' Assets Average plummeted by 2468.6% in 2022, and later surged by 31825.54% in 2024.
- Quarter analysis of 5 years shows Viking Therapeutics' Assets Average stood at $217.6 million in 2021, then decreased by 22.96% to $167.6 million in 2022, then skyrocketed by 124.08% to $375.6 million in 2023, then surged by 145.78% to $923.1 million in 2024, then dropped by 21.18% to $727.6 million in 2025.
- Its Assets Average stands at $727.6 million for Q4 2025, versus $783.6 million for Q3 2025 and $847.4 million for Q2 2025.